Time & Date: 3 September, 13.45 – 14.45 CEST
Chairperson(s): J-F. Korobelnik FRANCE
Speakers & Presentations:
J-F. Korobelnik FRANCE
Welcome and opening remarks
T.Y. Wong SINGAPORE
& P. Westenskow SWITZERLAND
Ang-2/VEGF-A dual inhibition in DME: Preclinical evidence and clinical findings
N. Holekamp USA
Exploring clinical and real-world case studies in DME in the context of Ang-2/VEGF-A dual inhibition
All Faculty
Panel discussion / Q&A
